These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3041793)

  • 21. [Influence of verapamil on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):248-64. PubMed ID: 754777
    [No Abstract]   [Full Text] [Related]  

  • 22. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
    Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
    Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Double-blind comparison of verapamil and propranolol in the therapy of unstable angina].
    Capucci A; Bracchetti D; Carini G; Di Ciò G; Maresta A; Magnani B
    Cardiologia; 1982; 27(5):447-52. PubMed ID: 6765439
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
    DiBianco R; Dickie KJ; Singh S; Katz RJ; Costello RB; Gottdiene JS; Laddu AR; Fletcher RD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Verapamil in the treatment of angina pectoris. Comparative double-blind study with fendilin].
    Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():63-7. PubMed ID: 354613
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of unstable angina with oral verapamil. Cross-over double-blind study].
    L'Abbate A; Parodi O; Maseri A
    Boll Soc Ital Cardiol; 1978; (1 Suppl):131-4. PubMed ID: 395962
    [No Abstract]   [Full Text] [Related]  

  • 30. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release verapamil in stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():20-3. PubMed ID: 3151265
    [No Abstract]   [Full Text] [Related]  

  • 32. [Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study].
    Lesbre JP; Lalau JD; Jaubourg ML; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):205-10. PubMed ID: 3285763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy.
    Weiner DA; McCabe CH; Cutler SS; Creager MA; Ryan TJ; Klein MD
    Am J Cardiol; 1983 May; 51(8):1251-5. PubMed ID: 6342351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of stable angina pectoris with verapamil hydrochloride: a double blind cross-over study.
    Simoons ML; Taams M; Lubsen J; Hugenholtz PG
    Eur Heart J; 1980 Aug; 1(4):269-74. PubMed ID: 6791924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Verapamil or propranolol for the treatment of angina pectoris].
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Ugeskr Laeger; 1982 Jan; 144(4):240-3. PubMed ID: 7041382
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
    Papa M; Acanfora D; Artiaco D; Santangelo L; Covelluzzi F; De Rosa ML; Cicatiello M; De Caprio L; Rengo F
    G Ital Cardiol; 1987 Apr; 17(4):344-50. PubMed ID: 3653591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic stable angina: comparison of verapamil and propranolol.
    Southall E; Nutt NR; Thomas RD
    J Int Med Res; 1982; 10(5):361-6. PubMed ID: 6754509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical and ergometric evaluation].
    de Brito FS; Pereira MH
    Arq Bras Cardiol; 1979 Jun; 32(6):415-21. PubMed ID: 389213
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of antianginal actions of verapamil and propranolol.
    Bowles MJ; Subramanian VB; Davies AB; Raftery EB
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1754. PubMed ID: 6786607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.